{
    "Trade/Device Name(s)": [
        "IBL Cortisol ELISA",
        "Cortisol ELISA test kit"
    ],
    "Submitter Information": "IBL Immuno Biological Laboratories",
    "510(k) Number": "K062626",
    "Predicate Device Reference 510(k) Number(s)": [
        "K052359",
        "K010790"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGR"
    ],
    "Summary Letter Date": "November 28, 2006",
    "Summary Letter Received Date": "November 30, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1205"
    ],
    "Regulation Name(s)": [
        "Cortisol (hydrocortisone and hydroxycorticosterone) test system"
    ],
    "Analyte Class(es)": [
        "endocrine",
        "chemistry"
    ],
    "Analyte(s)": [
        "Cortisol"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Saliva"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzyme-linked immunosorbent assay (ELISA)",
        "Solid phase competitive immunoassay"
    ],
    "Methodologies": [
        "Immunoassay",
        "ELISA"
    ],
    "Submission Type(s)": [
        "Kit",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for IBL Cortisol ELISA kit for quantitative determination of cortisol in human serum and saliva using solid phase ELISA.",
    "Indications for Use Summary": "Aid in the differential diagnosis of Cushing syndrome and Addison's disease by quantitative determination of cortisol in human serum and saliva.",
    "fda_folder": "Clinical Chemistry"
}